Independent Director · Vanda Pharmaceuticals Inc. (VNDA)

Charles C. Duncan — Vanda Pharmaceuticals Director Compensation (2025)

Fiscal year 2025 director compensation for Charles C. Duncan at Vanda Pharmaceuticals Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 23, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Charles C. Duncan’s full pay file as a PDF — free

More than this page: up to 10 years of Charles’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Charles C. Duncan and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Vanda Pharmaceuticals Director Compensation Table · the one fiscal year held
In US dollars, as Vanda Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$0$0$0$0—

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vanda Pharmaceuticals Inc. DEF 14A filed April 23, 2026, accession 0001628280-26-026893, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Vanda Pharmaceuticals Inc. filed document, accession 0001628280-26-026893. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2026.

Get the Vanda Pharmaceuticals Board Governance Report

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 23, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Vanda Pharmaceuticals pays directors a $50,000 cash retainer and $260,000 in equity.

The rest of the Vanda Pharmaceuticals board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Anne Sempowski WardIndependent Director$344,998
Mihael H. PolymeropoulosChair of the Board—
Phaedra S. ChrousosIndependent Director$339,998
Richard W. DuganLead Independent Director$374,998
Stephen Ray MitchellIndependent Director$317,498
Tage HonoréIndependent Director$327,498

The full Vanda Pharmaceuticals compensation record

free company brief

This page is one director within Vanda Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Vanda Pharmaceuticals proxy · each links to its own free brief

Order VNDA

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report